M. Kulyk & Associates’s Abbott ABT Stock Holding History

M. Kulyk & Associates’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,086	Closed	-$214K	–	114
2026 Q1	$214K	Buy	2,086 +26	+1%	+$2.94K	0.04%	115
2025 Q4	$258K	Buy	2,060 +1	+0%	+$127	0.05%	92
2025 Q3	$276K	Buy	2,059 +50	+2%	+$6.56K	0.06%	85
2025 Q2	$273K	Sell	2,009 -49	-2%	-$6.46K	0.06%	87
2025 Q1	$273K	Sell	2,058 -928	-31%	-$118K	0.06%	80
2024 Q4	$338K	Sell	2,986 -852	-22%	-$98.5K	0.07%	77
2024 Q3	$438K	Buy	3,838 +115	+3%	+$12.6K	0.09%	72
2024 Q2	$387K	Hold	3,723	–	–	0.09%	75
2024 Q1	$423K	Sell	3,723 -114	-3%	-$13.1K	0.1%	73
2023 Q4	$422K	Sell	3,837 -23	-0.6%	-$2.3K	0.1%	76
2023 Q3	$374K	Sell	3,860 -344	-8%	-$36.1K	0.1%	74
2023 Q2	$458K	Hold	4,204	–	–	0.13%	75
2023 Q1	$426K	Sell	4,204 -300	-7%	-$31.7K	0.13%	74
2022 Q4	$494K	Buy	4,504 +300	+7%	+$31.1K	0.17%	68
2022 Q3	$407K	Hold	4,204	–	–	0.14%	72
2022 Q2	$457K	Sell	4,204 -122	-3%	-$13.9K	0.14%	68
2022 Q1	$512K	Buy	4,326 +7	+0.2%	+$868	0.14%	66
2021 Q4	$608K	Buy	4,319 +2,423	+128%	+$310K	0.16%	57
2021 Q3	$224K	Hold	1,896	–	–	0.07%	68
2021 Q2	$220K	Hold	1,896	–	–	0.08%	60
2021 Q1	$227K	Buy	+1,896	New	+$225K	0.08%	67

Other funds holding ABT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

M. Kulyk & Associates's ABT Position: Q2 2026 in Review

M. Kulyk & Associates sold out of Abbott (ABT) in Q2 2026, closing a stake of 2,086 shares — an estimated $214K sold.

M. Kulyk & Associates first reported a position in ABT in Q1 2021 and held it in 21 quarters. The position peaked at $608K in Q4 2021. 2,968 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

M. Kulyk & Associates reported no remaining Abbott position as of Q2 2026 after selling out during the quarter.
M. Kulyk & Associates sold 2,086 Abbott shares in Q2 2026, an estimated $214K.
M. Kulyk & Associates first reported a position in Abbott in Q1 2021 and held it in 21 quarters.
M. Kulyk & Associates's Abbott position peaked at $608K in Q4 2021.
2,968 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on M. Kulyk & Associates's 13F filing for Q2 2026, filed 7 Aug 2026.